A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.

Terazosin in the treatment of benign prostatic hyperplasia: the United States experience.

Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial.

Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy.

Efficacy of once-a-day terazosin in benign prostatic hyperplasia: a randomized, double-blind placebo-controlled clinical trial.

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability.

Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study.

Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis.

Medical treatment of benign prostatic hyperplasia.

Treatment of benign prostatic hyperplasia with phytosterols.

Changing approaches in the treatment of benign prostatic hyperplasia.

Conservative treatment of benign prostatic hyperplasia.

Benign prostatic hyperplasia: a population-based study.

A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia.

Emerging drugs for the treatment of benign prostatic hyperplasia.

A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.

Medical treatment for benign prostatic hyperplasia.

Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.

Pathogenesis of benign prostatic hyperplasia.

Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.

Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study.

Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes.

The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.

Complications in hyperthermia treatment of benign prostatic hyperplasia.

Suggest Documents

The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia.

Terazosin in the treatment of benign prostatic hyperplasia: the United States experience.

Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial.

Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy.

Efficacy of once-a-day terazosin in benign prostatic hyperplasia: a randomized, double-blind placebo-controlled clinical trial.

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability.

Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study.

Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis.

Medical treatment of benign prostatic hyperplasia.

Treatment of benign prostatic hyperplasia with phytosterols.

Changing approaches in the treatment of benign prostatic hyperplasia.

Conservative treatment of benign prostatic hyperplasia.

Benign prostatic hyperplasia: a population-based study.

A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia.

Emerging drugs for the treatment of benign prostatic hyperplasia.

A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia.

Medical treatment for benign prostatic hyperplasia.

Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.

Pathogenesis of benign prostatic hyperplasia.

Comparison of the efficacy of isosorbide mononitrate and doxazosin in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: a randomized clinical trial.

Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study.

Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes.

The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.

Complications in hyperthermia treatment of benign prostatic hyperplasia.

A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

Recommend Documents

Follow Us